Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

What Are Wall Street Analysts' Target Price for Amgen Stock?

Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human therapeutics. With a market cap of $182.4 billion, the company focuses on human therapeutics and concentrates on innovating novel medicines based on cellular and molecular biology.

Shares of this drug manufacturing giant have underperformed the broader market over the past year. AMGN has gained 17.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 28.3%. In 2026, AMGN stock is up 3.3%, compared to the SPX’s 4.2% rise on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.